Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: A note of caution

Sunati Sahoo, Syed A. Hoda, Juan Rosai, Ronald A. DeLellis

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

To evaluate the expression of cytokeratin (CK) 19, we stained sections obtained from formalin-fixed, paraffin tissue blocks of 35 thyroid tumors (follicular adenoma [FA], 20; papillary thyroid carcinoma [PTC], 10 follicular variant [FV] and 5 usual type) and scored the extent of staining as follows: 1+ (<5% positively stained cells), 2+ (5%-25% positively stained cells), 3+ (25%-75% positively stained cells), and 4+ (> 75% positively stained cells). All 15 PTCs (including 10 FV-PTCs) were CK19 positive: 14 were 4+ and 1 (FV-PTC) was 2+. All 20 FAs also were CK19 positive: 15 were 1+, 1 was 2+, 4 were 3+, and none was 4+. In the FAs that were scored 1+, reactivity usually was confined to follicular cells lining cystically dilated atrophic follicles that lacked the typical nuclear features of PTC. The remaining FAs showed more diffuse reactivity, which was, however, less intense than that observed in the PTCs. Thus, immunoreactivity for CK19 is not specific for PTC, although we acknowledge that the extent and intensity of staining are considerably greater in this tumor than in FA. There were no significant differences in staining for CK19 between nonneoplastic follicles adjacent to PTCs and those adjacent to FAs.

Original languageEnglish (US)
Pages (from-to)696-702
Number of pages7
JournalAmerican Journal of Clinical Pathology
Volume116
Issue number5
DOIs
StatePublished - 2001

Fingerprint

Keratin-19
Factor IX
Staining and Labeling
Adenoma
Paraffin
Formaldehyde
Neoplasms
Thyroid Gland
Papillary Thyroid cancer

Keywords

  • Cytokeratin 19
  • Follicular adenoma
  • Immunohistochemistry
  • Papillary thyroid carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma : A note of caution. / Sahoo, Sunati; Hoda, Syed A.; Rosai, Juan; DeLellis, Ronald A.

In: American Journal of Clinical Pathology, Vol. 116, No. 5, 2001, p. 696-702.

Research output: Contribution to journalArticle

@article{e1e13381e17b41d2825af0b6a872a187,
title = "Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: A note of caution",
abstract = "To evaluate the expression of cytokeratin (CK) 19, we stained sections obtained from formalin-fixed, paraffin tissue blocks of 35 thyroid tumors (follicular adenoma [FA], 20; papillary thyroid carcinoma [PTC], 10 follicular variant [FV] and 5 usual type) and scored the extent of staining as follows: 1+ (<5{\%} positively stained cells), 2+ (5{\%}-25{\%} positively stained cells), 3+ (25{\%}-75{\%} positively stained cells), and 4+ (> 75{\%} positively stained cells). All 15 PTCs (including 10 FV-PTCs) were CK19 positive: 14 were 4+ and 1 (FV-PTC) was 2+. All 20 FAs also were CK19 positive: 15 were 1+, 1 was 2+, 4 were 3+, and none was 4+. In the FAs that were scored 1+, reactivity usually was confined to follicular cells lining cystically dilated atrophic follicles that lacked the typical nuclear features of PTC. The remaining FAs showed more diffuse reactivity, which was, however, less intense than that observed in the PTCs. Thus, immunoreactivity for CK19 is not specific for PTC, although we acknowledge that the extent and intensity of staining are considerably greater in this tumor than in FA. There were no significant differences in staining for CK19 between nonneoplastic follicles adjacent to PTCs and those adjacent to FAs.",
keywords = "Cytokeratin 19, Follicular adenoma, Immunohistochemistry, Papillary thyroid carcinoma",
author = "Sunati Sahoo and Hoda, {Syed A.} and Juan Rosai and DeLellis, {Ronald A.}",
year = "2001",
doi = "10.1309/6D9D-7JCM-X4T5-NNJY",
language = "English (US)",
volume = "116",
pages = "696--702",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "5",

}

TY - JOUR

T1 - Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma

T2 - A note of caution

AU - Sahoo, Sunati

AU - Hoda, Syed A.

AU - Rosai, Juan

AU - DeLellis, Ronald A.

PY - 2001

Y1 - 2001

N2 - To evaluate the expression of cytokeratin (CK) 19, we stained sections obtained from formalin-fixed, paraffin tissue blocks of 35 thyroid tumors (follicular adenoma [FA], 20; papillary thyroid carcinoma [PTC], 10 follicular variant [FV] and 5 usual type) and scored the extent of staining as follows: 1+ (<5% positively stained cells), 2+ (5%-25% positively stained cells), 3+ (25%-75% positively stained cells), and 4+ (> 75% positively stained cells). All 15 PTCs (including 10 FV-PTCs) were CK19 positive: 14 were 4+ and 1 (FV-PTC) was 2+. All 20 FAs also were CK19 positive: 15 were 1+, 1 was 2+, 4 were 3+, and none was 4+. In the FAs that were scored 1+, reactivity usually was confined to follicular cells lining cystically dilated atrophic follicles that lacked the typical nuclear features of PTC. The remaining FAs showed more diffuse reactivity, which was, however, less intense than that observed in the PTCs. Thus, immunoreactivity for CK19 is not specific for PTC, although we acknowledge that the extent and intensity of staining are considerably greater in this tumor than in FA. There were no significant differences in staining for CK19 between nonneoplastic follicles adjacent to PTCs and those adjacent to FAs.

AB - To evaluate the expression of cytokeratin (CK) 19, we stained sections obtained from formalin-fixed, paraffin tissue blocks of 35 thyroid tumors (follicular adenoma [FA], 20; papillary thyroid carcinoma [PTC], 10 follicular variant [FV] and 5 usual type) and scored the extent of staining as follows: 1+ (<5% positively stained cells), 2+ (5%-25% positively stained cells), 3+ (25%-75% positively stained cells), and 4+ (> 75% positively stained cells). All 15 PTCs (including 10 FV-PTCs) were CK19 positive: 14 were 4+ and 1 (FV-PTC) was 2+. All 20 FAs also were CK19 positive: 15 were 1+, 1 was 2+, 4 were 3+, and none was 4+. In the FAs that were scored 1+, reactivity usually was confined to follicular cells lining cystically dilated atrophic follicles that lacked the typical nuclear features of PTC. The remaining FAs showed more diffuse reactivity, which was, however, less intense than that observed in the PTCs. Thus, immunoreactivity for CK19 is not specific for PTC, although we acknowledge that the extent and intensity of staining are considerably greater in this tumor than in FA. There were no significant differences in staining for CK19 between nonneoplastic follicles adjacent to PTCs and those adjacent to FAs.

KW - Cytokeratin 19

KW - Follicular adenoma

KW - Immunohistochemistry

KW - Papillary thyroid carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0035735719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035735719&partnerID=8YFLogxK

U2 - 10.1309/6D9D-7JCM-X4T5-NNJY

DO - 10.1309/6D9D-7JCM-X4T5-NNJY

M3 - Article

C2 - 11710686

AN - SCOPUS:0035735719

VL - 116

SP - 696

EP - 702

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 5

ER -